Philips point-of-care ultrasound technology now includes Pulse Wave Doppler for all physicians
Royal Philips has announced that it has expanded its ultrasound portfolio with advanced hemodynamic assessment and measurement capabilities on its handheld point-of-care ultrasound – Lumify. With the addition of Pulse Wave Doppler, Philips has expanded the utility of Lumify enabling clinicians to quantify blood flow in a wide range of point-of-care diagnostic applications including cardiology, vascular, abdominal, urology, obstetrics and gynecology. Also new to Lumify are obstetric measurements to help in early assessment of gestational age and the identification of high-risk pregnancies.
Pulse Wave Doppler ultrasound provides clinicians with more information, in addition to 2D and color imaging, to assess hemodynamic patterns to differentiate between arterial and venous blood flow and quantify hemodynamic function. The resulting hemodynamic measurements can enhance diagnostic confidence and timely clinical decision-making in virtually any care setting, including cardiology and emergency medicine. With these latest features, Lumify brings together imaging tools across ultrasound platforms, leveraging the company’s expertise in cardiology and radiology.
The Lumify system also provides clinicians with advanced analysis software and reporting tools, and access to tele-ultrasound capabilities for live communication support to connect clinicians around the globe for real-time collaboration.